This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jun;63(6):1829-30.

doi: 10.2337/db14-0366.

DPP-4 inhibitors-renoprotection in diabetic nephropathy?

Usha Panchapakesan¹, Carol A Pollock²

Affiliations

Affiliations

¹ Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St. Leonards, New South Wales, Australia usha.panchapakesan@sydney.edu.au.
² Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St. Leonards, New South Wales, Australia.

PMID: 24853893
DOI: 10.2337/db14-0366

Comment

DPP-4 inhibitors-renoprotection in diabetic nephropathy?

Usha Panchapakesan et al. Diabetes. 2014 Jun.

. 2014 Jun;63(6):1829-30.

doi: 10.2337/db14-0366.

Authors

Usha Panchapakesan¹, Carol A Pollock²

Affiliations

¹ Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St. Leonards, New South Wales, Australia usha.panchapakesan@sydney.edu.au.
² Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St. Leonards, New South Wales, Australia.

PMID: 24853893
DOI: 10.2337/db14-0366

No abstract available

PubMed Disclaimer

Comment on

Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
Kanasaki K, Shi S, Kanasaki M, He J, Nagai T, Nakamura Y, Ishigaki Y, Kitada M, Srivastava SP, Koya D. Kanasaki K, et al. Diabetes. 2014 Jun;63(6):2120-31. doi: 10.2337/db13-1029. Epub 2014 Feb 26. Diabetes. 2014. PMID: 24574044

Similar articles

Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
Kanasaki K, Shi S, Kanasaki M, He J, Nagai T, Nakamura Y, Ishigaki Y, Kitada M, Srivastava SP, Koya D. Kanasaki K, et al. Diabetes. 2014 Jun;63(6):2120-31. doi: 10.2337/db13-1029. Epub 2014 Feb 26. Diabetes. 2014. PMID: 24574044
[Pharmacological and clinical profiles of the DPP-4 inhibitor linagliptin (Trazenta)].
Ohmura T, Hayashi N, Encinas J. Ohmura T, et al. Nihon Yakurigaku Zasshi. 2012 Apr;139(4):174-83. doi: 10.1254/fpj.139.174. Nihon Yakurigaku Zasshi. 2012. PMID: 22498683 Review. Japanese. No abstract available.
DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy.
Alter ML, Ott IM, von Websky K, Tsuprykov O, Sharkovska Y, Krause-Relle K, Raila J, Henze A, Klein T, Hocher B. Alter ML, et al. Kidney Blood Press Res. 2012;36(1):119-30. doi: 10.1159/000341487. Epub 2012 Oct 15. Kidney Blood Press Res. 2012. PMID: 23171828
Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice.
Darsalia V, Olverling A, Larsson M, Mansouri S, Nathanson D, Nyström T, Klein T, Sjöholm Å, Patrone C. Darsalia V, et al. Regul Pept. 2014 May;190-191:25-31. doi: 10.1016/j.regpep.2014.05.001. Epub 2014 May 10. Regul Pept. 2014. PMID: 24821550
Linagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.
Tiwari A. Tiwari A. Curr Opin Investig Drugs. 2009 Oct;10(10):1091-104. Curr Opin Investig Drugs. 2009. PMID: 19777398 Review.

See all similar articles

Cited by

The role of cellular crosstalk in the progression of diabetic nephropathy.
Zhang K, Fu Z, Zhang Y, Chen X, Cai G, Hong Q. Zhang K, et al. Front Endocrinol (Lausanne). 2023 Jul 17;14:1173933. doi: 10.3389/fendo.2023.1173933. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37538798 Free PMC article. Review.
[Diabetic kidney disease - Update 2016].
Sourij H, Edlinger R, Prischl F, Auinger M, Kautzky-Willer A, Säemann MD, Prager R, Clodi M, Schernthaner G, Mayer G, Oberbauer R, Rosenkranz AR. Sourij H, et al. Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S85-96. doi: 10.1007/s00508-016-0992-y. Wien Klin Wochenschr. 2016. PMID: 27052231 Review. German.
More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling.
Gupta S, Sen U. Gupta S, et al. Pharmacol Res. 2019 Sep;147:104391. doi: 10.1016/j.phrs.2019.104391. Epub 2019 Aug 8. Pharmacol Res. 2019. PMID: 31401210 Free PMC article. Review.
Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy.
Sifuentes-Franco S, Padilla-Tejeda DE, Carrillo-Ibarra S, Miranda-Díaz AG. Sifuentes-Franco S, et al. Int J Endocrinol. 2018 Apr 1;2018:1875870. doi: 10.1155/2018/1875870. eCollection 2018. Int J Endocrinol. 2018. PMID: 29808088 Free PMC article. Review.
New therapeutic agents in diabetic nephropathy.
Kim Y, Park CW. Kim Y, et al. Korean J Intern Med. 2017 Jan;32(1):11-25. doi: 10.3904/kjim.2016.174. Epub 2017 Jan 1. Korean J Intern Med. 2017. PMID: 28049280 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal